CARGO Therapeutics (CRGX) Competitors $4.47 +0.07 (+1.59%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CRGX vs. IMNM, QURE, PHAR, XERS, CRON, MENS, REPL, VIR, SION, and GYREShould you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Immunome (IMNM), uniQure (QURE), Pharming Group (PHAR), Xeris Biopharma (XERS), Cronos Group (CRON), Jyong Biotech (MENS), Replimune Group (REPL), Vir Biotechnology (VIR), Sionna Therapeutics (SION), and Gyre Therapeutics (GYRE). These companies are all part of the "pharmaceutical products" industry. CARGO Therapeutics vs. Its Competitors Immunome uniQure Pharming Group Xeris Biopharma Cronos Group Jyong Biotech Replimune Group Vir Biotechnology Sionna Therapeutics Gyre Therapeutics CARGO Therapeutics (NASDAQ:CRGX) and Immunome (NASDAQ:IMNM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations. Do institutionals & insiders hold more shares of CRGX or IMNM? 93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 44.6% of Immunome shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by insiders. Comparatively, 8.6% of Immunome shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate CRGX or IMNM? CARGO Therapeutics currently has a consensus target price of $15.00, suggesting a potential upside of 235.57%. Immunome has a consensus target price of $23.33, suggesting a potential upside of 167.89%. Given CARGO Therapeutics' higher possible upside, equities analysts plainly believe CARGO Therapeutics is more favorable than Immunome.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Immunome 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CRGX or IMNM more profitable? CARGO Therapeutics has a net margin of 0.00% compared to Immunome's net margin of -1,875.21%. CARGO Therapeutics' return on equity of -45.93% beat Immunome's return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -45.93% -39.58% Immunome -1,875.21%-71.65%-60.36% Does the media refer more to CRGX or IMNM? In the previous week, Immunome had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 2 mentions for Immunome and 0 mentions for CARGO Therapeutics. Immunome's average media sentiment score of 0.70 beat CARGO Therapeutics' score of 0.00 indicating that Immunome is being referred to more favorably in the news media. Company Overall Sentiment CARGO Therapeutics Neutral Immunome Positive Which has more risk & volatility, CRGX or IMNM? CARGO Therapeutics has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500. Comparatively, Immunome has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Which has better valuation & earnings, CRGX or IMNM? CARGO Therapeutics has higher earnings, but lower revenue than Immunome. Immunome is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97Immunome$9.04M83.83-$292.96M-$3.18-2.74 SummaryImmunome beats CARGO Therapeutics on 8 of the 15 factors compared between the two stocks. Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRGX vs. The Competition Export to ExcelMetricCARGO TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$205.65M$2.92B$5.56B$9.05BDividend YieldN/A2.44%5.24%3.99%P/E Ratio-0.9721.5627.6520.23Price / SalesN/A283.26419.56119.26Price / CashN/A41.7026.2128.59Price / Book0.577.538.035.65Net Income-$167.50M-$55.14M$3.18B$249.15M7 Day Performance6.68%4.61%2.93%3.28%1 Month Performance-5.89%0.90%1.72%3.95%1 Year Performance-70.92%5.40%34.39%20.98% CARGO Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRGXCARGO Therapeutics1.4841 of 5 stars$4.47+1.6%$15.00+235.6%-70.9%$205.65MN/A-0.97116Positive NewsIMNMImmunome2.4317 of 5 stars$9.30+6.0%$23.33+150.9%-27.6%$763.10M$9.04M-2.9240High Trading VolumeQUREuniQure2.1206 of 5 stars$13.94+0.6%$37.82+171.3%+277.2%$759.19M$27.12M-3.18500News CoveragePHARPharming Group2.8916 of 5 stars$10.68-2.9%$30.00+181.0%+27.2%$748.58M$297.20M-53.38280Positive NewsGap DownHigh Trading VolumeXERSXeris Biopharma3.6202 of 5 stars$4.67-0.6%$6.25+33.8%+125.4%$735.01M$222.55M-15.57290CRONCronos Group2.0073 of 5 stars$1.91+0.5%N/A-8.5%$732.80M$117.61M14.69450News CoverageMENSJyong BiotechN/A$8.50-10.5%N/AN/A$722.26MN/A0.0031REPLReplimune Group4.1737 of 5 stars$9.29-0.4%$20.83+124.3%+16.5%$719.22MN/A-3.03210News CoverageAnalyst ForecastVIRVir Biotechnology3.2017 of 5 stars$5.04-2.5%$32.86+551.9%-35.6%$714.69M$74.21M-1.19580News CoveragePositive NewsInsider TradeSIONSionna TherapeuticsN/A$17.35+9.5%$38.50+121.9%N/A$698.92MN/A0.0035Positive NewsInsider TradeGYREGyre Therapeutics0.0779 of 5 stars$7.35-0.9%N/A-34.5%$695.68M$105.76M367.6840 Related Companies and Tools Related Companies IMNM Competitors QURE Competitors PHAR Competitors XERS Competitors CRON Competitors MENS Competitors REPL Competitors VIR Competitors SION Competitors GYRE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRGX) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRGX Stock Alerts